Centessa Pharmaceuticals (NASDAQ:CNTA) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Centessa Pharmaceuticals (CNTA) operate in?

Centessa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Centessa Pharmaceuticals Stock (NASDAQ: CNTA) stock price, news, charts, stock research, profile.

Open	$17.54
Close	-
Volume / Avg.	151.68K / 546.85K
Day Range	$16.46 - $17.78
52 Wk Range	6.65 - 18.97
Market Cap	$2.20B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	3.12%
Days to Cover	4.64

Recent News

Cassava Sciences, Biohaven And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Avi Kapoor

Maximus Reports Weak Earnings, Joins Atkore, PDD Holdings And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Avi Kapoor

Wake Up to This Biotech Stock That Still Has Big Potential Upside

Centessa Pharmaceuticals (NASDAQ:CNTA) is a biotechnology stock that has nearly doubled its value so far this year, and its run may not be over. Analysts at Morgan Stanley have just massively raised their

MarketBeat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Aug

Sep

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$17.54
Close	-
Volume / Avg.	151.68K / 546.85K
Day Range	$16.46 - $17.78
52 Wk Range	6.65 - 18.97
Market Cap	$2.20B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	3.12%
Days to Cover	4.64

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Centessa Pharmaceuticals (CNTA) stock?

You can purchase shares of Centessa Pharmaceuticals (NASDAQ:CNTA) through any online brokerage.

View our list of the best stock brokerages

Who are Centessa Pharmaceuticals (CNTA) competitors?

Other companies in Centessa Pharmaceuticals’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), SpringWorks Therapeutics (NASDAQ:SWTX), Protagonist Therapeutics (NASDAQ:PTGX), Mesoblast (NASDAQ:MESO) and Arrowhead Pharma (NASDAQ:ARWR).

What is the forecast, or price target, for Centessa Pharmaceuticals (CNTA) stock?

Centessa Pharmaceuticals has a consensus price target of $18.80.

What is the current price for Centessa Pharmaceuticals (CNTA)?

The stock price for Centessa Pharmaceuticals (NASDAQ: CNTA) is $17.53 last updated December 23, 2024 at 4:00 PM EST.

Does Centessa Pharmaceuticals (CNTA) pay a dividend?

There are no upcoming dividends for Centessa Pharmaceuticals.

When is Centessa Pharmaceuticals (NASDAQ:CNTA) reporting earnings?

Centessa Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 12, 2024.

Is Centessa Pharmaceuticals (CNTA) going to split?

There is no upcoming split for Centessa Pharmaceuticals.

What sector and industry does Centessa Pharmaceuticals (CNTA) operate in?

Centessa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Centessa Pharmaceuticals

Centessa Pharmaceuticals (CNTA) Forecast